Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis
Background: Patients with venous thromboembolism have high risk of recurrence after discontinuation of anticoagulant treatment. Extended anticoagulation, such as traditional anticoagulants, can reduce the risk of recurrence but is associated with increased risk of hemorrhage. Sulodexide is a natural...
Main Authors: | Qing-Jun Jiang, Jun Bai, Jie Jin, Jian Shi, Lefeng Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00876/full |
Similar Items
-
Comparative Efficacy and Safety of Sulodexide and Other Extended Anticoagulation Treatments for Prevention of Recurrent Venous Thromboembolism: A Bayesian Network Meta-analysis
by: Giuseppe Pompilio, et al.
Published: (2020-04-01) -
Place of Sulodexide in the Renoprotektivе Therapy of Patients with Chronic Kidney Disease
by: M. M. Batyushin, et al.
Published: (2012-03-01) -
Venous Thromboembolism in Pregnancy: Challenges and Solutions
by: Varrias D, et al.
Published: (2023-07-01) -
Prevention of Venous Thromboembolism in 2020 and Beyond
by: Matthew Nicholson, et al.
Published: (2020-08-01) -
N-Acetylcysteine and Sulodexide Reduce the Prothrombotic Effect of Uremic Serum on the Venous Endothelial Cells
by: Patrycja Sosinska-Zawierucha, et al.
Published: (2019-04-01)